Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Nov;85(5):573-607.
doi: 10.1016/j.jinf.2022.08.003. Epub 2022 Aug 5.

Performance of existing definitions and tests for the diagnosis of invasive aspergillosis in critically ill, non-neutropenic, adult patients: An update including COVID-19 data

Matteo Bassetti  1 , Valentina Zuccaro  2 , Erika Asperges  2 , Luigia Scudeller  3 , Daniele Roberto Giacobbe  4 ; FUNDICU investigators (collaborators)
Collaborators, Affiliations

Performance of existing definitions and tests for the diagnosis of invasive aspergillosis in critically ill, non-neutropenic, adult patients: An update including COVID-19 data

Matteo Bassetti et al. J Infect. 2022 Nov.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest Outside the submitted work, DRG reports investigator-initiated grants from Pfizer, Shionogi, and Gilead Italia, and speaker and/or advisory board fees from Pfizer and Tillotts Pharma. Outside the submitted work, MB reports research grants and/or advisor/consultant and/or speaker/chairman fees from Bayer, BioMérieux, Cidara, Cipla, Gilead, Menarini, MSD, Pfizer, and Shionogi. The other authors have no conflict of interests to disclose.

Figures

Fig 1
Fig. 1
Flow diagram of the study selection process, Modified from Moher et al..
Fig 2
Fig. 2
Risk of bias in included studies.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

  • Invasive Fungal Diseases in Adult Patients in Intensive Care Unit (FUNDICU): 2024 consensus definitions from ESGCIP, EFISG, ESICM, ECMM, MSGERC, ISAC, and ISHAM.
    Bassetti M, Giacobbe DR, Agvald-Ohman C, Akova M, Alastruey-Izquierdo A, Arikan-Akdagli S, Azoulay E, Blot S, Cornely OA, Cuenca-Estrella M, de Lange DW, De Rosa FG, De Waele JJ, Dimopoulos G, Garnacho-Montero J, Hoenigl M, Kanj SS, Koehler P, Kullberg BJ, Lamoth F, Lass-Flörl C, Maertens J, Martin-Loeches I, Muñoz P, Poulakou G, Rello J, Sanguinetti M, Taccone FS, Timsit JF, Torres A, Vazquez JA, Wauters J, Asperges E, Cortegiani A, Grecchi C, Karaiskos I, Le Bihan C, Mercier T, Mortensen KL, Peghin M, Rebuffi C, Tejada S, Vena A, Zuccaro V, Scudeller L, Calandra T; Study Group for Infections in Critically Ill Patients of the European Society of Clinical Microbiology and Infectious Diseases (ESGCIP), the Fungal Infection Study Group of the European Society of Clinical Microbiology and Infectious Diseases (EFISG), the European Society of Intensive Care Medicine (ESICM), the European Confederation of Medical Mycology (ECMM), the Mycoses Study Group Education and Research Consortium (MSGERC), the International Society of Antimicrobial Chemotherapy (ISAC), the International Society for Human and Animal Mycology (ISHAM), the Austrian Society for Medical Mycology (ÖGMM), the Italian So… See abstract for full author list ➔ Bassetti M, et al. Intensive Care Med. 2024 Apr;50(4):502-515. doi: 10.1007/s00134-024-07341-7. Epub 2024 Mar 21. Intensive Care Med. 2024. PMID: 38512399 Free PMC article.
  • [S1 guideline: diagnosis and treatment of invasive pulmonary aspergillosis in critically ill/intensive care patients].
    Wichmann D, Hoenigl M, Koehler P, Koenig C, Lund F, Mang S, Strauß R, Weigand M, Hohmann C, Kurzai O, Heußel C, Kochanek M. Wichmann D, et al. Med Klin Intensivmed Notfmed. 2025 May;120(4):271-289. doi: 10.1007/s00063-025-01265-w. Epub 2025 Mar 21. Med Klin Intensivmed Notfmed. 2025. PMID: 40116920 Review. German. No abstract available.

References

    1. Bassetti M., Giacobbe D.R., Grecchi C., Rebuffi C., Zuccaro V., Scudeller L., et al. Performance of existing definitions and tests for the diagnosis of invasive aspergillosis in critically ill, adult patients: a systematic review with qualitative evidence synthesis. J Infect. 2020;81:131–146. - PubMed
    1. Bassetti M., Scudeller L., Giacobbe D.R., Lamoth F., Righi E., Zuccaro V., et al. Developing definitions for invasive fungal diseases in critically ill adult patients in intensive care units. Protocol of the fungal infections definitions in ICU patients (FUNDICU) project. Mycoses. 2019;62:310–319. - PubMed
    1. Moher D., Liberati A., Tetzlaff J., Altman D.G., Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6 - PMC - PubMed
    1. Ergun M., Bruggemann R.J.M., Alanio A., Delliere S., van Arkel A., Bentvelsen R.G., et al. Aspergillus test profiles and mortality in critically ill COVID-19 patients. J Clin Microbiol. 2021;59 - PMC - PubMed
    1. Giacobbe D.R., Prattes J., Wauters J., Dettori S., Signori A., Salmanton-Garcia J., et al. Prognostic impact of bronchoalveolar lavage fluid galactomannan and aspergillus culture results on survival in COVID-19 intensive care unit patients: a post hoc analysis from the european confederation of medical mycology (ECMM) COVID-19-associated pulmonary aspergillosis study. J Clin Microbiol. 2022;60 - PMC - PubMed